News & Events

Sep 24, 2018

CathWorks FFRangio™ System files FDA 510(k) submission.

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

READ MORE

Aug 15, 2018

CathWorks Fast-FFR trial enrollment completed early.

CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio™ System in terms of sensitivity and specificity when compared to conventional invasive Fractional Flow Reserve (FFR).

READ MORE

Sep 24, 2018 – San Diego, CA

TCT 2018

Lunch Presentation Theater Program

FFRangio for PCI Guidance:
A Clinical Review

READ MORE